Medicines Formulary

Reports

Status	Drug name	NICE TAs	Comments
	Psoriderm®
	Pyridoxine tablets
	Quinine sulphate
	Ramipril capsules		Ramipril (as capsules) has the most robust evidence base and is considered to be the first line agent of choice.
	Renavit		Dietary management of water-soluble vitamin deficiency in adults with renal failure on dialysis.
	Repaglinide tablets
	Repevax		Supported with PGD
	Revaxis		Supported with PGD
	Rigevidon		Umbrella service only
	Risendronate tablets

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.